NovaBay Pharmaceuticals CEO Justin Hall's 2021 pay rises 6% to $796K
NovaBay Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: March 30, 2022
NovaBay Pharmaceuticals reported fiscal year 2021 executive compensation information on March 30, 2022.
In 2021, three executives at NovaBay Pharmaceuticals received on average a compensation package of $552K, a 18% increase compared to previous year.
Average pay of disclosed executives at NovaBay Pharmaceuticals
Justin M. Hall, Chief Executive Officer, received $796K in total, which increased by 6% compared to 2020. 50% of Hall's compensation, or $395K, was in stock awards. Hall also received $70K in bonus, $329K in salary, as well as $1.9K in other compensation.
Andrew Jones, Chief Financial Officer, received a compensation package of $565K, which decreased by 23% compared to previous year. 52% of the compensation package, or $292K, was in salary.
Audrey Kunin, Chief Product Officer, earned $295K in 2021.
Related executives
You may also like
Source: SEC filing on March 30, 2022.